At Kratz Allergy & Asthma, we use Fasenra to treat severe eosinophilic asthma. Fasenra is a highly effective medication that has been approved by the FDA for the treatment of severe eosinophilic asthma in patients aged 12 years and older. In clinical trials, Fasenra has been shown to significantly reduce
If you suffer from severe allergic asthma or chronic idiopathic urticaria, Xolair injection may be a recommended treatment option. Xolair is a monoclonal antibody that works by targeting and blocking Immunoglobulin E (IgE) to reduce the severity and frequency of allergic reactions. Before undergoing an Xolair injection, it is essential
Asthma affects over 25 million people in America. Treating this condition requires a vetted asthma specialist. Learn to streamline the vetting process.
Asthma is a lung condition that commonly develops during childhood. In fact, about 1 in 12 children, aged 0 to 17 in the United States have asthma. As a parent, understanding the signs of asthma can help you identify the condition in your child and ensure that they receive the